Top compounds associated with response to EIF5


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib UHNBreast pan-cancer AAC 0.095 0.7
mRNA BRD8899 CTRPv2 pan-cancer AAC 0.013 0.7
mRNA BIRB 0796 CTRPv2 pan-cancer AAC 0.013 0.7
mRNA 17-AAG CCLE pan-cancer AAC 0.015 0.8
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.012 0.8
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.011 0.8
mRNA BRD-A86708339 CTRPv2 pan-cancer AAC 0.016 0.8
mRNA JQ-1:MK-0752 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.011 0.8
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.017 0.8
mRNA TG-101348 CTRPv2 pan-cancer AAC 0.011 0.8
Download CSV